CVS Caremark President Named PCMA Board Chair
Pharmacy benefit management operators should monitor this leadership shift at the industry’s trade group.
Updated on Sept. 21, 2026 in People
Live Poll
Do you trust that pharmacy benefit managers effectively lower prescription drug costs for your household?
The Pharmaceutical Care Management Association (PCMA) has appointed Ed DeVaney as the new Chair of its Board of Directors. DeVaney succeeds Adam Kautzner, who concluded his term leading the trade organization.
Why it matters
The change in board leadership at the PCMA represents a shift in representation for the pharmacy benefit management industry as it faces ongoing regulatory scrutiny. Operators should watch for changes in the group's advocacy focus under DeVaney's tenure.
The transition brings 25 years of industry experience to the helm of the association. This change impacts the governing board of the PCMA, which represents pharmacy benefit managers nationwide.
The players
Ed DeVaney
Executive Vice President and President of CVS Caremark with over 25 years of industry experience.
Adam Kautzner
President of Evernorth Care Management and Express Scripts who served as the previous PCMA Board Chair.
David Marin
President and CEO of the PCMA, the trade association representing pharmacy benefit managers.
The details
Ed DeVaney, who serves as Executive Vice President and President of CVS Caremark, steps into the role effective immediately following the conclusion of Adam Kautzner’s term. DeVaney will work alongside PCMA President and CEO David Marin to steer the organization's policy and advocacy efforts. The board leadership change reflects the current structural evolution within major health care services firms.
Timeline
September 21, 2026: PCMA announced the appointment of Ed DeVaney as Board Chair.
Market Landscape
This leadership transition follows the established pattern of board rotation within the PCMA. The shift reflects broader efforts by the pharmacy benefit management industry to align its trade representation with the priorities of its major member firms.
Operators in the health care supply chain should monitor PCMA policy communications for shifts in advocacy stance. This leadership change may signal new priorities in how the organization interacts with regulatory bodies and legislative stakeholders.
The takeaway
The appointment of a CVS Caremark executive to lead the industry's primary trade group underscores the influence of major pharmacy benefit managers in policy discussions. Monitor upcoming PCMA position statements to determine if new advocacy priorities align with your specific firm's operational focus.
Further reading
For more on industry leadership trends, visit the People section.
Source note: This article includes information reported by Firstwordpharma.
Live Poll
Do you trust that pharmacy benefit managers effectively lower prescription drug costs for your household?
